Published in Blood on July 30, 2007
Bone Marrow Stromal Cells for Inflammatory Bowel Diseases | NCT01851343
Control of stem cell fate by physical interactions with the extracellular matrix. Cell Stem Cell (2009) 5.43
Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell (2012) 3.33
Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms. Mol Ther (2009) 3.20
A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One (2010) 3.14
Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol (2009) 3.07
Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell (2012) 2.87
Mesenchymal stem cell therapy: Two steps forward, one step back. Trends Mol Med (2010) 2.86
Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S A (2010) 2.74
Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One (2010) 2.38
Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol (2009) 2.37
Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes (2008) 2.25
Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc (2008) 1.98
Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells (2010) 1.98
Discrepancy between the in vitro and in vivo effects of murine mesenchymal stem cells on T-cell proliferation and collagen-induced arthritis. Arthritis Res Ther (2010) 1.95
Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systems. Disaster Med Public Health Prep (2011) 1.93
Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol (2014) 1.90
Neuroprotective effects of intravitreal mesenchymal stem cell transplantation in experimental glaucoma. Invest Ophthalmol Vis Sci (2009) 1.79
Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes (2009) 1.78
Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thorac Soc (2011) 1.66
Clinical applications of mesenchymal stem cells in soft tissue augmentation. Aesthet Surg J (2010) 1.54
Kidney-derived stromal cells modulate dendritic and T cell responses. J Am Soc Nephrol (2009) 1.51
Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med (2009) 1.49
Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. Am J Physiol Lung Cell Mol Physiol (2012) 1.44
Systemically delivered insulin-like growth factor-I enhances mesenchymal stem cell-dependent fracture healing. Growth Factors (2012) 1.42
Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice. J Bone Miner Res (2010) 1.41
Journey of mesenchymal stem cells for homing: strategies to enhance efficacy and safety of stem cell therapy. Stem Cells Int (2012) 1.41
Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model. Stem Cells (2008) 1.38
Concise review: Mesenchymal stem cell treatment of the complications of diabetes mellitus. Stem Cells (2011) 1.35
Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy (2009) 1.35
Cell-based therapy in ischemic stroke. Expert Rev Neurother (2008) 1.33
Bone marrow-derived mesenchymal stromal cells inhibit Th2-mediated allergic airways inflammation in mice. Stem Cells (2011) 1.33
Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis. PLoS One (2011) 1.33
Fracture healing: mechanisms and interventions. Nat Rev Rheumatol (2014) 1.33
Natural history of mesenchymal stem cells, from vessel walls to culture vessels. Cell Mol Life Sci (2013) 1.31
Analysis of allogenicity of mesenchymal stem cells in engraftment and wound healing in mice. PLoS One (2009) 1.31
Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PLoS One (2011) 1.30
Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens. Stem Cells (2008) 1.28
Allogeneic mesenchymal stem cell treatment alleviates experimental and clinical Sjögren syndrome. Blood (2012) 1.27
Cell therapy of congenital corneal diseases with umbilical mesenchymal stem cells: lumican null mice. PLoS One (2010) 1.26
Cell sources for bone regeneration: the good, the bad, and the ugly (but promising). Tissue Eng Part B Rev (2011) 1.26
Mesenchymal stem cells suppress B-cell terminal differentiation. Exp Hematol (2009) 1.25
Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis. Mol Ther (2009) 1.24
Mesenchymal stem cell therapy for nonhealing cutaneous wounds. Plast Reconstr Surg (2010) 1.24
New concepts on the immune modulation mediated by mesenchymal stem cells. Stem Cell Res Ther (2010) 1.24
An inducible caspase 9 suicide gene to improve the safety of mesenchymal stromal cell therapies. Stem Cells (2010) 1.23
Lipopolysaccharide activates Toll-like receptor 4 (TLR4)-mediated NF-κB signaling pathway and proinflammatory response in human pericytes. J Biol Chem (2013) 1.23
The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron (2010) 1.23
Concise review: the periosteum: tapping into a reservoir of clinically useful progenitor cells. Stem Cells Transl Med (2012) 1.22
Emerging roles for multipotent, bone marrow-derived stromal cells in host defense. Blood (2012) 1.20
Fibroblastic reticular cells from lymph nodes attenuate T cell expansion by producing nitric oxide. PLoS One (2011) 1.20
Role of mesenchymal stromal cells in solid organ transplantation. Transplant Rev (Orlando) (2008) 1.17
Radiation rescue: mesenchymal stromal cells protect from lethal irradiation. PLoS One (2011) 1.17
Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts. Mol Med (2011) 1.17
Human cord blood stem cell-modulated regulatory T lymphocytes reverse the autoimmune-caused type 1 diabetes in nonobese diabetic (NOD) mice. PLoS One (2009) 1.16
Role of mesenchymal stem cells on cornea wound healing induced by acute alkali burn. PLoS One (2012) 1.14
CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties. PLoS One (2013) 1.13
Mesenchymal stromal cells: a new tool against graft-versus-host disease? Biol Blood Marrow Transplant (2011) 1.11
Hypoxic culture conditions as a solution for mesenchymal stem cell based regenerative therapy. ScientificWorldJournal (2013) 1.10
Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment. Cancer Res (2014) 1.10
Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors. Haematologica (2009) 1.10
Mesenchymal stem cell-based therapy. Mol Pharm (2012) 1.09
Tumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds. Stem Cells (2009) 1.09
Mechanisms underlying the osteo- and adipo-differentiation of human mesenchymal stem cells. ScientificWorldJournal (2012) 1.09
Stem cells and regenerative medicine in lung biology and diseases. Mol Ther (2012) 1.08
Mesenchymal stromal cells improve survival during sepsis in the absence of heme oxygenase-1: the importance of neutrophils. Stem Cells (2013) 1.08
Mesenchymal stem cells and granulomas in Crohn's disease and intestinal tuberculosis: the way forward. Dig Dis Sci (2013) 1.07
Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. Adv Drug Deliv Rev (2012) 1.07
Mesenchymal stem cells at the intersection of cell and gene therapy. Expert Opin Biol Ther (2010) 1.07
Mesenchymal stem cells from umbilical cord matrix, adipose tissue and bone marrow exhibit different capability to suppress peripheral blood B, natural killer and T cells. Stem Cell Res Ther (2013) 1.07
Comparison of the therapeutic effects of human and mouse adipose-derived stem cells in a murine model of lipopolysaccharide-induced acute lung injury. Stem Cell Res Ther (2013) 1.07
Reversing bone loss by directing mesenchymal stem cells to bone. Stem Cells (2013) 1.06
Allogeneic mesenchymal stem cells transplantation in patients with refractory RA. Clin Rheumatol (2011) 1.05
To grab the stroma by the horns: from biology to cancer therapy with mesenchymal stem cells. Oncotarget (2013) 1.05
Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation. Biol Blood Marrow Transplant (2010) 1.04
Gingivae contain neural-crest- and mesoderm-derived mesenchymal stem cells. J Dent Res (2013) 1.04
The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential. Br Med Bull (2013) 1.04
Clinical review: Stem cell therapies for acute lung injury/acute respiratory distress syndrome - hope or hype? Crit Care (2012) 1.04
Therapy with stem cells in inflammatory bowel disease. World J Gastroenterol (2014) 1.03
Characterization of bone marrow derived mesenchymal stem cells in suspension. Stem Cell Res Ther (2012) 1.03
Stem cell therapy: a novel & futuristic treatment modality for disaster injuries. Indian J Med Res (2012) 1.00
Long-lasting effects of human mesenchymal stem cell systemic administration on pain-like behaviors, cellular, and biomolecular modifications in neuropathic mice. Front Integr Neurosci (2011) 1.00
The current landscape of the mesenchymal stromal cell secretome: A new paradigm for cell-free regeneration. Cytotherapy (2015) 1.00
Bone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson's disease and multiple system atrophy. J Clin Neurol (2009) 0.99
A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression. Cytotherapy (2014) 0.99
Stem cell treatment for patients with autoimmune disease by systemic infusion of culture-expanded autologous adipose tissue derived mesenchymal stem cells. J Transl Med (2011) 0.99
Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE. Nat Rev Rheumatol (2010) 0.99
Cloned, CD117 selected human amniotic fluid stem cells are capable of modulating the immune response. PLoS One (2011) 0.99
Human umbilical cord mesenchymal stem cells reduce systemic inflammation and attenuate LPS-induced acute lung injury in rats. J Inflamm (Lond) (2012) 0.98
Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism. Clin Exp Allergy (2011) 0.98
Mesenchymal stromal cells for cardiovascular disease. J Cardiovasc Dis Res (2011) 0.98
Mesenchymal stem cells promote alveolar epithelial cell wound repair in vitro through distinct migratory and paracrine mechanisms. Respir Res (2013) 0.98
Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease-A Phase II Study. Stem Cells Int (2011) 0.97
The effect of mesenchymal stromal cell-hyaluronic acid hydrogel constructs on immunophenotype of macrophages. Tissue Eng Part A (2011) 0.97
Mesenchymal stem cells for treatment of CNS injury. Curr Neuropharmacol (2010) 0.97
Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids. Sci Rep (2014) 0.97
Cardiac Stem Cell Hybrids Enhance Myocardial Repair. Circ Res (2015) 0.97
Labeling human mesenchymal stem cells with gold nanocages for in vitro and in vivo tracking by two-photon microscopy and photoacoustic microscopy. Theranostics (2013) 0.96
Concise review: stem/progenitor cells for renal tissue repair: current knowledge and perspectives. Stem Cells Transl Med (2013) 0.96
Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol (2008) 4.94
Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells (2004) 3.98
Sarcoma derived from cultured mesenchymal stem cells. Stem Cells (2006) 3.40
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood (2006) 3.16
Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut (2010) 3.09
Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell (2013) 3.01
Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells. J Immunol (2006) 3.00
Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood (2003) 2.57
Mesenchymal stem cells in human second-trimester bone marrow, liver, lung, and spleen exhibit a similar immunophenotype but a heterogeneous multilineage differentiation potential. Haematologica (2003) 2.23
Canonical wnt signaling regulates hematopoiesis in a dosage-dependent fashion. Cell Stem Cell (2011) 2.18
Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol (2002) 2.05
Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. JAMA (2009) 1.99
Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica (2008) 1.80
Mesenchymal stromal cells. Ann N Y Acad Sci (2009) 1.76
Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl Med (2013) 1.68
Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial. Blood (2007) 1.60
Defining the risks of mesenchymal stromal cell therapy. Cytotherapy (2010) 1.60
Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice. Proc Natl Acad Sci U S A (2002) 1.50
Electrophysiological and arrhythmogenic effects of intramyocardial bone marrow cell injection in patients with chronic ischemic heart disease. Heart Rhythm (2006) 1.46
Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Transl Med (2013) 1.44
Pretreatment with interferon-γ enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis. Stem Cells (2011) 1.38
Human adult bone marrow mesenchymal stem cells repair experimental conduction block in rat cardiomyocyte cultures. J Am Coll Cardiol (2005) 1.35
Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction. Am J Cardiol (2007) 1.31
T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events. Blood (2002) 1.31
Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease. Br J Haematol (2013) 1.31
Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells (2013) 1.31
Nonexpanded primary lung and bone marrow-derived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol (2003) 1.25
Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency. Blood (2006) 1.22
Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders. Ann N Y Acad Sci (2012) 1.22
Self-renewing human bone marrow mesenspheres promote hematopoietic stem cell expansion. Cell Rep (2013) 1.20
Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6. Haematologica (2013) 1.17
Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization. Proc Natl Acad Sci U S A (2006) 1.17
Opportunities and challenges for mesenchymal stem cell-mediated heart repair. Curr Opin Lipidol (2007) 1.14
Multipotent mesenchymal stromal cell therapy in renal disease and kidney transplantation. Nephrol Dial Transplant (2009) 1.10
Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors. Haematologica (2009) 1.10
Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance. Blood (2005) 1.09
Gap junctional coupling with cardiomyocytes is necessary but not sufficient for cardiomyogenic differentiation of cocultured human mesenchymal stem cells. Stem Cells (2012) 0.98
Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia. J Nucl Med (2006) 0.98
Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-up. J Cardiovasc Transl Res (2013) 0.97
Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy. Cytotherapy (2013) 0.97
Differential maturation of megakaryocyte progenitor cells from cord blood and mobilized peripheral blood. Exp Hematol (2003) 0.96
Clinical outcomes after peripheral blood stem cell donation by related donors: a Dutch single-center cohort study. Transfusion (2012) 0.94
Wnt3a nonredundantly controls hematopoietic stem cell function and its deficiency results in complete absence of canonical Wnt signaling. Blood (2010) 0.92
Intramyocardial bone marrow-derived mononuclear cell injection for chronic myocardial ischemia: the effect on diastolic function. Circ Cardiovasc Imaging (2011) 0.91
Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease. Biol Blood Marrow Transplant (2004) 0.90
MSCs: science and trials. Nat Med (2013) 0.90
Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: involvement of endotoxins as cofactors in mobilization. Blood (2003) 0.89
Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit. Exp Hematol (2005) 0.88
Enhancement of G-CSF-induced stem cell mobilization by antibodies against the beta 2 integrins LFA-1 and Mac-1. Blood (2002) 0.88
Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve-month follow-up results. Am Heart J (2006) 0.88
Cardiomyogenic differentiation-independent improvement of cardiac function by human cardiomyocyte progenitor cell injection in ischaemic mouse hearts. J Cell Mol Med (2012) 0.88
Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia. Am J Cardiol (2006) 0.88
Gata1 expression driven by the alternative HS2 enhancer in the spleen rescues the hematopoietic failure induced by the hypomorphic Gata1low mutation. Blood (2009) 0.87
Involvement of proteases in cytokine-induced hematopoietic stem cell mobilization. Ann N Y Acad Sci (2005) 0.86
Outcomes after myeloablative unrelated donor stem cell transplantation using both in vitro and in vivo T-cell depletion with alemtuzumab. Haematologica (2006) 0.85
Ex vivo culture of human CD34+ cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model. Exp Hematol (2006) 0.85
Myeloid cells are tunable by a polyanionic polysaccharide derivative and co-determine host rescue from lethal virus infection. J Leukoc Biol (2010) 0.84
Homeostasis of telomere length rather than telomere shortening after allogeneic peripheral blood stem cell transplantation. Blood (2002) 0.83
Repeated hematopoietic stem and progenitor cell mobilization without depletion of the bone marrow stem and progenitor cell pool in mice after repeated administration of recombinant murine G-CSF. Hum Immunol (2007) 0.83
Oral complications and management considerations in patients treated with high-dose chemotherapy. Support Cancer Ther (2004) 0.83
CD97 is differentially expressed on murine hematopoietic stem-and progenitor-cells. Haematologica (2008) 0.83
Chimerism levels after stem cell transplantation are primarily determined by the ratio of donor to host stem cells. Blood (2011) 0.83
Effect of intramyocardial bone marrow cell injection on diastolic function in patients with chronic myocardial ischemia. J Magn Reson Imaging (2008) 0.82
Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease. Cytotherapy (2011) 0.82
Hematopoietic stem and progenitor cells are differentially mobilized depending on the duration of Flt3-ligand administration. Haematologica (2010) 0.81
Targeting host B-cell immune responses by persistent donor NK-cell alloreactivity following nonmyeloablative allogeneic stem cell transplantation. Blood (2007) 0.81
Serpina1 (alpha1-AT) is synthesized in the osteoblastic stem cell niche. Exp Hematol (2009) 0.80
Reduced-intensity conditioning allogeneic stem cell transplantation with donor T-cell depletion using alemtuzumab added to the graft ('Campath in the bag'). Curr Opin Oncol (2009) 0.79
Raising hematology's European voice: the importance of calling yourself a hematologist. Haematologica (2012) 0.79
High dose chemotherapy and autologous hematopoietic stem cell transplantation for rheumatoid arthritis: a review. Hum Immunol (2002) 0.79
Differential role of CD97 in interleukin-8-induced and granulocyte-colony stimulating factor-induced hematopoietic stem and progenitor cell mobilization. Haematologica (2008) 0.78
Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustion. Br J Haematol (2002) 0.78
Multipotent stromal cells skew monocytes towards an anti-inflammatory function: the link with key immunoregulatory molecules. Haematologica (2013) 0.78
A sensitive quantitative single-platform flow cytometry protocol to measure human platelets in mouse peripheral blood. Transfusion (2007) 0.77
Telomerase mutations in aplastic anemia. N Engl J Med (2005) 0.77
Post-myocardial infarct inflammation and the potential role of cell therapy. Cardiovasc Drugs Ther (2015) 0.77
Effect of intramyocardial bone marrow-derived mononuclear cell injection on cardiac sympathetic innervation in patients with chronic myocardial ischemia. Int J Cardiovasc Imaging (2014) 0.76
Intramyocardial bone marrow cell transplantation and the progression of coronary atherosclerosis in patients with chronic myocardial ischemia. Acute Card Care (2007) 0.76
Wnt cross-talk in the niche. Blood (2012) 0.75
Meeting summary: International Symposium and Workshop on Hematopoietic Stem Cells VI, University of Tübingen, Germany, September 14-16, 2006. Exp Hematol (2007) 0.75
Persisting NK cell alloreactivity in the presence of long-term stable hematopoietic chimerism. Exp Hematol (2009) 0.75
Peripheral blood hematopoietic stem and progenitor cell frequency is unchanged in patients with alpha-1-antitrypsin deficiency. Int J Hematol (2014) 0.75
Meeting summary: International Symposium and Workshop on Hematopoietic Stem Cells V, University of Tübingen, Germany, September 16-18, 2004. Exp Hematol (2005) 0.75
International Symposium and Workshop on hematopoietic stem cells VII, University of Tübingen, Germany, September 18-20, 2008. Ann N Y Acad Sci (2009) 0.75
Long term effects of intramyocardial bone marrow cell injection on anginal symptoms and quality of life in patients with chronic myocardial ischemia. Int J Cardiol (2013) 0.75
Meeting summary: International Symposium and Workshop on Hematopoietic Stem Cells IV, University of Tübingen, Germany, September 19-21, 2002. Exp Hematol (2003) 0.75